ArticleSurgical endoscopy2025
Implementation of the enhanced recovery after bariatric surgery (ERABS) protocol with clinical hypnosis: effects on pain and postoperative nausea and vomiting (PONV) management in bariatric surgery.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionObesity is a major global health issue requiring tailored anesthetic and analgesic strategies due to associated physiological and pharmacokinetic changes. The Enhanced Recovery After Bariatric Surgery (ERABS) protocol has been introduced to optimize perioperative care, but its implementation remains inconsistent. This pilot study investigates the integration of a perioperative clinical hypnosis (CH) protocol with ERABS to assess its effects on postoperative pain, nausea, and analgesic/antiemetic drug consumption in patients undergoing bariatric and metabolic surgery (BMS). MATERIALS AND
methodsA total of 42 patients undergoing elective gastric bypass were enrolled and divided into two groups: one receiving standard ERABS protocol plus CH (Group A) and the other receiving only ERABS (Group B). Pain levels, nausea, and medication use were assessed at 12 and 24 h post-surgery.
resultsResults showed a significant reduction in pain in the CH group at both 12 h (mean NRS: 2.9 vs. 5.8, p = 0.0007) and 24 h (mean NRS: 1.4 vs. 3.3, p = 0.0019). CH also led to a reduction in rescue analgesic use at 12 h (p = 0.05), though no significant differences were found at 24 h. Postoperative nausea and vomiting incidence was lower in the CH group but did not reach statistical significance.
conclusionsThese findings suggest that perioperative CH could be a valuable adjunct to ERABS, improving postoperative pain management and reducing analgesic consumption in the first 12 h post-surgery. Given the study's limitations, including small sample size and single-center design, further multicenter trials are recommended to confirm these preliminary results and explore the underlying mechanisms of CH in surgical recovery.
Indexed as
Identifiers
40866595What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.